Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter

Syncope Clinical Trial

Official title: A Randomized Controlled Study to Identify Clinically Actionable Arrhythmia Using the ePatch® Extended Wear Holter vs. Standard Wear Holter

Status Recruiting

Clinical Trial Summary

This study is a Multi-center, prospective, randomized, unblinded, two-arm study to assess if 7-days of cardiac monitoring using the ePatch Holter results in identification of more clinically actionable arrythmia for patients with symptoms of syncope than standard 24 hour Holter monitoring.

Clinical Trial Description

This study is a multi-center, prospective, randomized, unblinded, two-arm study to assess if 7-days of cardiac monitoring using the ePatch Holter results in identification of more clinically actionable arrythmia for patients with symptoms of syncope than standard 24 hour Holter monitoring. Approximately 256 adult subjects with symptoms of syncope will be randomized 1:1 to wear either the Philips ePatch Extended Wear Holter (7 day) or Standard Wear Holter (24 hours). Randomization will be balanced for gender. ;

Related Conditions & MeSH terms

• Arrhythmias, Cardiac
• Arrythmia
• Syncope

• NCT number: NCT06310707
• Study type: Interventional
• Source: Philips Clinical & Medical Affairs Global
• Contact: Purvee Parikh
• Phone: +1 619-929-6310
• Email: purvee.parikh@philips.com
• Status: Recruiting
• Phase: N/A
• Start date: November 9, 2023
• Completion date: August 2025